Telix Pharmaceuticals Lim... (TLX)

NasdaqGS: TLX · リアルタイム株価 · USD

11.88

+0.15 (1.28%)

終値時点： Aug 19, 2026, 3:59 PM

1.28% (1D)

買気配	11.78
時価総額	4.11B
売上高（TTM）	803.79M
純利益（TTM）	-7.13M
ベータ	0.60
EPS（TTM）	-0.02
PER（TTM）	n/a
予想PER	85.23
PBR（TTM）	9.89
PSR（TTM）	5.11
Earnings Date	n/a

売気配	10.32
出来高	42,691
平均出来高（20日）	158,151
始値	11.87
前日終値	11.73
当日レンジ	11.84 - 11.98
52週レンジ	6.28 - 12.60
アナリスト	n/a
目標株価	n/a
配当	n/a
権利落ち日	n/a

TLXについて

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with adv...

[続きを読む]

業種 Biotechnology

セクター Healthcare

IPO日 Nov 14, 2024

従業員数 1,120

上場取引所 NasdaqGS

ティッカー TLX

ウェブサイト https://telixpharma.com

企業情報の全文

業績

2025年のTelix Pharmaceuticalsの売上高は803.79Mで、前年の516.55Mから55.61%の増加でした。利益は-7.13Mで、-121.15%の減少でした。

財務諸表

ニュース

2週間前 · Simply Wall St.

Why Regeneron (REGN) Is Up 6.7% After Mixed Q2 Results And New Telix Oncology Deal

Regeneron Pharmaceuticals reported past second-quarter 2026 results with revenue rising to US$4,290.7 million from US$3,675.6 million a year earlier, while net income slipped to US$1,296.9 million and...

3週間前 · Pharma Voice

How Telix landed a $2.1 billion radiopharma deal with Regeneron

Regeneron tapped the Aussie biotech to enter the radiopharma market with a multi-pronged agreement.

4週間前 · Zacks

Does Telix Pharmaceuticals Limited (TLX) Have the Potential to Rally 86.17% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 86.2% in Telix Pharmaceuticals Limited (TLX). While the effectiveness of this highly sought-after metric is que...

1か月前 · Pharmaceutical Technology

Telix opens radiopharmaceutical facility in Australia for cancer treatment

The facility aims to address manufacturing capacity challenges and bring production and patient administration closer together.

2か月前 · Insider Monkey

Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best new stocks to buy with the huge upside potential. On June 2, Telix Pharmaceuticals and United Imaging Healthcare signed an MoU to establi...

2ページ中1ページ

Telix Pharmaceuticals Lim... (TLX)

TLXについて

業績

決算サプライズ

Why Price Moved